Asset Details
Do you wish to reserve the book?
Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy
Do you wish to request the book?
Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy
2020
Overview
This study aimed to evaluate the potential of oral probiotics to eradicate vaginal GBS colonization during the third trimester of pregnancy. We screened 1058 women for GBS colonization at 33–37 gestational weeks using a combination of vaginal-to-rectal swab and culture-based methods. Women who tested GBS positive were randomized to either the verum group, receiving a dietary probiotic supplement of four viable strains of
Lactobacillus
twice-daily for 14 days, or to the placebo group. Women underwent follow-up smears, whereat GBS colonization upon follow-up was considered the primary endpoint. We found that 215 women (20.3%) were positive for GBS upon screening, of which 82 (38.1%) were eligible for study inclusion; 41 (50%) of these were randomized to the verum and placebo groups each. After treatment, 21/33 (63.6%) members of the verum group, and 21/27 (77.8%) of the placebo group were still GBS positive (
p
= 0.24). Four (9.8%) women in the verum group and one (2.4%) in the placebo group experienced preterm birth (
p
= 0.20); smokers showed significantly higher rates of preterm birth (
p
= 0.03). Hence, the findings did not support the hypothesis that oral probiotics can eradicate GBS during pregnancy, although we observed a trend toward reduced GBS persistence after probiotic intake.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/499
/ Adult
/ Birth
/ Female
/ Humanities and Social Sciences
/ Humans
/ NCT
/ Pregnancy Complications, Infectious - microbiology
/ Pregnancy Complications, Infectious - prevention & control
/ Premature Birth - microbiology
/ Premature Birth - prevention & control
/ Probiotics - administration & dosage
/ Rectum
/ Science
/ Streptococcal Infections - microbiology
/ Streptococcal Infections - prevention & control
/ Streptococcus agalactiae - drug effects
/ Vagina
